News

Ferrari's Strategic Share Buyback Under Euro 2 Billion Program

Ferrari's Strategic Share Buyback Under Euro 2 Billion Program

Ferrari's Ongoing Share Buyback Program

Ferrari N.V. has recently informed its investors about the continuation of its share buyback program, a strategic approach to enhance shareholder value. Ferrari, listed under NYSE and EXM with the ticker RACE, initiated a new tranche of its buyback scheme, which was previously announced with a budget of Euro 150 million. This marks the sixth tranche in a comprehensive, multi-year buyback program totaling approximately Euro 2 billion, expected to conclude by 2026.

Details of the Share Buyback Activity

The company has been meticulously executing this buyback program since its disclosure during the 2022 Capital Markets Day. As of a recent date, Ferrari reported the purchase of multiple shares on both the Euronext Milan and the New York Stock Exchange, providing transparency through daily aggregated reporting.

Key Statistics from the Program

From the start of the latest tranche to a recent date, Ferrari has invested significantly in its own shares. The numbers reveal that:

  • Euro 19,741,895.00 was spent for acquiring a total of 45,980 common shares on the Euronext Milan.
  • Furthermore, on the New York Stock Exchange, it invested USD 2,499,852.21 (approximately Euro 2,382,854.07) to acquire 5,513 shares.

Company's Current Shareholding Structure

As of the recent report, Ferrari holds a treasury of 14,819,901 common shares, equating to about 5.77% of the total issued share capital. This current status indicates a well-managed approach to capital allocation, aiming to optimize the shareholder value while maintaining adequate liquidity for operational needs.

Historical Context of the Buyback Program

Initiated during the summer of 2022, the extensive buyback strategy has seen Ferrari repurchase a sizable number of shares. Up to now, they have acquired almost 4 million shares—specifically, 3,997,137—across both exchanges, entailing a total expenditure of approximately Euro 1,194,861,205.11. Such actions not only signal confidence in the company’s potential but also show commitment to returning value to shareholders.

Ferrari’s Reflections on Market Movements

In the context of changing market dynamics, Ferrari’s management has emphasized the importance of the buyback program as part of their long-term financial strategy. By actively purchasing shares, they aim to counteract market fluctuations which affect capital structure and stock prices while ensuring that investor interests remain at the forefront.

Insight into Future Plans

With the buyback program still in play, Ferrari has positioned itself to adapt to market conditions, focusing on strategic long-term growth. The comprehensive overview of transactions, which updates shareholders about previous and ongoing buyback measures, is accessible through the company’s corporate website. These initiatives indicate Ferrari’s proactive stance towards maintaining robust investor relationships.

Frequently Asked Questions

What is the purpose of Ferrari's share buyback program?

Ferrari's share buyback program aims to enhance shareholder value by repurchasing its shares, thereby reducing the number available in the market and supporting stock prices.

How many shares has Ferrari bought so far?

As of the latest report, Ferrari has repurchased a total of 3,997,137 shares since the program started in July 2022.

What is the total budget for Ferrari's share buyback program?

The total budget for the ongoing share buyback program is approximately Euro 2 billion.

How will the buyback impact Ferrari’s financials?

The buyback is expected to boost the earnings per share and positively influence investor perception, ultimately supporting stock performance.

Where can I find more information about the buyback program?

Additional details regarding Ferrari's buyback program can be found on their corporate website under the Buyback Programs section.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading